The drugs and devices have been on the market for years. But FDA-ordered studies still aren’t done.
-
By
-
David Hilzenrath
-
September 22, 2026
-
14 min
By
David Hilzenrath
September 22, 2026
by David Hilzenrath
September 22, 2026
Automated blood cell measurements distinguished active disease from remission with performance comparable to ESR in a small pediatric cohort.
November 5, 2026
A patient with biopsy-confirmed renal disease achieved remission during immunosuppressive therapy while maintaining stable HIV control.
October 23, 2026
A rapidly growing forearm nodule developed within weeks of tattoo placement, adding to previous reports of tumors arising in red pigment.
November 6, 2026